Atea Pharmaceuticals, Inc. (AVIR) vs Senseonics Holdings, Inc. (SENS)

A side-by-side comparison of Atea Pharmaceuticals, Inc. and Senseonics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVIR vs SENS

growth of $100 · dividends reinvested · last 6y
AVIR -83.1% (-25.6%/yr)SENS +44.2% (+6.3%/yr)SENS compounded faster over this window
Log scale — wide-divergence pair
1101001k10kStart $100202120222023202420252026$17$144
AVIR SENS

AVIR vs SENS: by the numbers

  • •SENS is the larger company ($419M vs $409M market cap).
  • •Both run net losses; AVIR's is the smaller (0.00% vs -225.34% net margin).

Metrics side by side

Valuation

MetricAVIRSENS
P/S ratioN/A8.64
P/B ratio2.004.64

Profitability

MetricAVIRSENS
Gross margin0.00%44.71%
Operating margin0.00%-193.83%
Net margin0.00%-225.34%
ROE-80.96%-121.12%
ROIC-89.93%-71.22%

Growth (annualized)

MetricAVIRSENS
Revenue CAGR (5Y)N/A35.10%
Total return CAGR (5Y)-34.44%-30.89%

Frequently asked

How have AVIR and SENS total returns compared?
Over the past 5 years, AVIR delivered -34.44% and SENS delivered -30.89% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.